Usa Patient Healthcare action Provident Adderall shortage Usa

Call to Action! Speak Up to End the ADHD Drug Shortage

Reading now: 799

Add your voice to the chorus of individuals with ADHD calling for an end to the ADHD medication shortage. Use the templates below to act on the following calls to action:The Federal Trade Commission (FTC) and U.S.

Department of Health and Human Services (HHS) are seeking public input to understand how lack of competition and contracting practices by two pharmaceutical drug middlemen groups — group purchasing organizations (GPOs) and drug wholesalers — may be contributing to drug shortages.The agencies are seeking public input on a variety of subjects under this topic, including whether and to what extent lack of competition among these pharmaceutical middlemen groups impacts patients, hospitals, healthcare providers (including small healthcare providers and rural hospitals), pharmacies, generic manufacturers, and other suppliers.Submit comments by April 15, 2024 at

Dear Representative,Millions of American caregivers and patients with attention deficit hyperactivity disorder (ADHD) have endured unprecedented healthcare disruptions and adverse outcomes since the Federal Drug Administration first reported shortage of Adderall, the amphetamine mixed salts used to treat ADHD, in October 2022.Patient advocates and legislators have called on federal agencies to help combat the nationwide Adderall shortage, yet it continues to impact the health and wellbeing of millions.

The website is an aggregator of articles from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the article if you find it unreliable.

Related articles